Skip to content

CEDAV Med

Active Private limited companyfounded 2021active for 5 yearsClos de l' Epaisse Haie 4, 7050 JurbiseKBO/BCE: BE 0773.725.646

Lifetime

5 annual accounts with figures on one time axis
peak of €202,446 in 2025
€202,446▲ 3.2%
peak of €121,179 in 2025
€121,179unchanged
peak of €297,069 in 2024
€132,353▼ 55.4%
€319,116▲ 175%
Board1 name since 2021
1 director
Documentsfilings and deeds
27-08-202627 days late
2025micro format
Dividend €285,896Equity from €297,069 to €132,353Debts from €115,931 to €319,116Cash from €134,269 to €209,179

Key points

from the 2025 annual accounts

Equity

€132,353 ▼ 55.4%
297,0692024+121,179Profit-285,896Dividend132,3532025

CEDAV Med paid out €285,896 in dividends. That is 236% of the 2025 profit.

Turnover

≈ €500,000 estimated

The micro format states no turnover.

Debts

€319,116 71% of the balance sheet
Financial debts 14%Suppliers 0%Taxes and wages 11%Other 76%

Of this, €274,355 falls due within a year.

Liquidity

1.03 was 5.16 in 2024

Short-term debts rose from €42,130 to €274,355.

Filings

5 annual accounts 5 late
AprilJune31 JulyOctober20222024

The 2023 accounts came in latest, 30 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,684 companies had the same profile as CEDAV Med has now. Each dot stands for 7 companies, two years later.

97.2%
were still trading
1.3%
stopped another way
1.3%
went bankrupt
  • Small
  • 5 to 10 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,684 companies, not a prediction for CEDAV Med. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 10-09-2021
  • founderdeed of 14-09-2021
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0773725646
Registered office moved from Saint-Ghislain to Jurbise The registered office moved from Rue du Port 130 Boîte 1, 7330 Saint-Ghislain to Clos de L'Epaisse Haie 4, 7050 Jurbise · General meeting of 21-06-2022 · Gazette deed
Incorporation Founding capital of €20,000, 100 shares · Founded by (fondatrice comparante) · appointed as director · published on 14-09-2021 · Gazette deed
First establishment At the time the registered office was still in Saint-Ghislain, Rue du Port 130 Boîte 1.
All 13 events

Official details

Source: KBO
Status
Active since 10-09-2021Normal situation
Activity
General medical practiceNACE 862101 activity on the establishment unitFrom the articles, 6 activities
Establishment unit
2.322.511.5807050 Jurbise, registered on 10-09-2021
Financial year end
31 December
Peppol
Reachable since 04-12-2025
Company details

Annual accounts 2025

€451,468▲ 9.3%
Filing
Filed on 27-08-2026
Financials

Insights on CEDAV Med

CEDAV Med files the micro format. That format states no turnover. The gross margin rose from €36,975 in 2021 to €202,446 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CEDAV Med

What is the company number of CEDAV Med?
The company number of CEDAV Med is 0773.725.646. The VAT number is the same number with BE in front: BE 0773.725.646.
Where is CEDAV Med based?
The registered office is at Clos de l' Epaisse Haie 4, 7050 Jurbise.Company details
What does CEDAV Med do?
According to the KBO register, the main activity of the establishment unit is general medical practice (NACE 86210).
What is the legal form of CEDAV Med?
CEDAV Med is a private limited company (BV).
When was CEDAV Med founded?
CEDAV Med was founded on 10-09-2021.
Is CEDAV Med still active?
Yes, CEDAV Med is an active enterprise in the KBO register.
What is the turnover of CEDAV Med?
The turnover in financial year 2025 is about €500,000. This figure is estimated from the gross margin of €202,446 and 2,454 comparable companies of the same size. It probably lies between €330,000 and €780,000. It is a rough estimate.Financials
Is CEDAV Med profitable?
In financial year 2025, CEDAV Med made a profit of €121,179.
Where can I find the annual accounts of CEDAV Med?
CEDAV Med filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CEDAV Med due?
CEDAV Med must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.